Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SOMATIC ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.5% 2.5%   Bankruptcy risk   7.6% 3.9% 3.7% 14.8% 2.3% 2.3% 9.4% 9.4%   Credit score (0-100)   33 51 52 13 64 64 26 26   Credit rating   BB BBB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   578 1,105 1,387 10,637 -79.6 -38.3 0.0 0.0   EBITDA   45.6 340 187 8,992 -79.6 -38.3 0.0 0.0   EBIT   16.8 317 164 8,966 -79.6 -38.3 0.0 0.0   Pre-tax profit (PTP)   -7.0 304.1 151.9 8,955.7 -109.0 63.0 0.0 0.0   Net earnings   -12.8 244.1 118.0 7,228.2 -109.0 63.0 0.0 0.0   Pre-tax profit without non-rec. items   -7.0 304 152 8,956 -109 63.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   72.1 49.0 25.8 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   36.6 281 399 7,364 3,057 3,121 3,021 3,021   Interest-bearing liabilities   140 63.9 8.2 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   430 856 1,140 9,766 3,068 3,133 3,021 3,021   Net Debt   -146 -411 -648 -9,754 -1,706 -414 -3,021 -3,021     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   578 1,105 1,387 10,637 -79.6 -38.3 0.0 0.0   Gross profit growth   -33.2% 91.1% 25.6% 666.6% 0.0% 51.9% 0.0% 0.0%   Employees   2 2 3 3 0 0 0 0   Employee growth %   0.0% 0.0% 50.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   430 856 1,140 9,766 3,068 3,133 3,021 3,021   Balance sheet change%   -29.9% 99.0% 33.1% 756.9% -68.6% 2.1% -3.6% 0.0%   Added value   45.6 340.0 186.8 8,992.1 -53.8 -38.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -45 -46 -46 -52 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.9% 28.7% 11.8% 84.3% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.8% 49.3% 16.4% 164.4% -1.2% 2.9% 0.0% 0.0%   ROI %   5.1% 121.5% 43.6% 230.8% -1.5% 2.9% 0.0% 0.0%   ROE %   -29.7% 153.8% 34.7% 186.2% -2.1% 2.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   8.5% 32.8% 35.0% 75.4% 99.7% 99.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -321.1% -121.0% -346.8% -108.5% 2,142.5% 1,081.8% 0.0% 0.0%   Gearing %   383.3% 22.8% 2.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.0% 12.4% 32.5% 260.7% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 1.4 1.5 4.1 161.6 48.7 0.0 0.0   Current Ratio   0.9 1.4 1.5 4.1 161.6 48.7 0.0 0.0   Cash and cash equivalent   286.9 475.4 656.1 9,754.3 1,706.1 414.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -35.5 231.7 372.9 7,364.0 1,707.5 618.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   23 170 62 2,997 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   23 170 62 2,997 0 0 0 0   EBIT / employee   8 158 55 2,989 0 0 0 0   Net earnings / employee   -6 122 39 2,409 0 0 0 0